Flash Glucose Monitoring Data May Help Predict Pregnancy Outcomes in Type 1 Diabetes

Researchers examined data from 70 pregnant women with Type 1 diabetes who used flash glucose monitoring systems during their pregnancies. The women had a median age of 36 years and had lived with diabetes for an average of 20 years. The study looked at whether specific glucose metrics tracked by these devices could predict which pregnancies would face complications.

The researchers tracked several glucose measurements: time in range (TIR)—the percentage of time glucose stayed within target—time above range (TAR), time below range (TBR), and glucose variability, which measures how much glucose levels fluctuate. They compared these metrics across all three trimesters of pregnancy.

Women who experienced adverse outcomes—defined as fetal or neonatal death, large-for-gestational-age babies, NICU admission, or newborn hypoglycemia—had notably different glucose patterns than those with uncomplicated pregnancies.

The most striking finding involved second trimester time in range: women who spent less than 69.5% of their time within target glucose ranges during the second trimester had a 10.56-fold increased risk of complications. High glucose variability in the first trimester—defined as 31.85% or higher—was associated with a 6.42-fold increased risk.

These associations remained significant even after adjusting for baseline HbA1c levels, suggesting that the detailed glucose patterns tracked by flash monitors provided information beyond what average blood sugar measurements alone could show.

This research suggests that flash glucose monitoring systems could help clinicians identify which pregnant women with Type 1 diabetes face higher risk and may benefit from closer monitoring or adjusted treatment strategies. The focus on specific glucose patterns during particular trimesters points to times when glucose control may matter most.

However, this was a relatively small study that looked back at data already collected. The findings need to be confirmed in larger prospective studies before they can guide clinical practice. Additionally, this research shows associations—that certain glucose patterns were more common in pregnancies with complications—but does not prove that changing these patterns would prevent complications.

The women in this study had an average pre-pregnancy HbA1c of 7.3%, and 41% had some degree of diabetic retinopathy at the start of pregnancy. These factors provide context for interpreting the results but also mean findings may not apply equally to all pregnant women with Type 1 diabetes.

If you are pregnant or planning pregnancy with Type 1 diabetes, discuss these findings with your healthcare team. They can help interpret your own glucose data and determine what targets and monitoring approach make sense for your individual situation.

Source: Endocrinologia, diabetes y nutricion. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.